Maternal HLA antigens and antibodies to SS-A/Ro and SS-B/La. Comparison with systemic lupus erythematosus and primary Sjögren's syndrome - PubMed (original) (raw)
Comparative Study
Maternal HLA antigens and antibodies to SS-A/Ro and SS-B/La. Comparison with systemic lupus erythematosus and primary Sjögren's syndrome
H Julkunen et al. Br J Rheumatol. 1995 Oct.
Abstract
To study the maternal immunogenetics in congenital heart block (CHB), 31 mothers of affected children were HLA typed for class I and II antigens, and the results were compared with the corresponding HLA types in 900 healthy controls, in 45 mothers with systemic lupus erythematosus (SLE) and in 21 mothers with primary SS who had healthy children. An enzyme-linked immunosorbent assay was used to study the autoantibody responses to the recombinant 52 and 60 kDa SS-A/Ro, and 48 kDa SS-B/La proteins, and to the affinity-purified SS-A/Ro and SS-B/La antigens. Mothers of children with CHB had HLA B8 and DR3 significantly more often than healthy controls [71 vs 10%; relative risk (RR) 9.8, P < 0.00001 and 74 vs 23%; RR9.8, P < 0.001, respectively]. HLA B35 was protective (RR 0.1, P = 0.0029). Compared to controls with SLE, mothers of children with CHB were more often HLA DR3 and DQ2 positive (RR 4.1, P = 0.0057 and RR 3.1, P = 0.031, respectively), and compared to controls with primary SS less often HLA B15 positive (RR 0.1, P = 0.010). In general, the HLA antigen profile in mothers of children with CHB was more closely related to primary SS than to SLE. Levels of antibodies to all three SS-A/Ro antigens were significantly higher in mothers of children with CHB than in controls with SLE and primary SS (P = 0.0001-0.0014). With regard to SS-B/La, the autoantibody responses were similar (P = 0.32-0.66).(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- DNA typing of maternal HLA in congenital complete heart block: comparison with systemic lupus erythematosus and primary Sjögren's syndrome.
Colombo G, Brucato A, Coluccio E, Compasso S, Luzzana C, Franceschini F, Quinzanini M, Scorza R. Colombo G, et al. Arthritis Rheum. 1999 Aug;42(8):1757-64. doi: 10.1002/1529-0131(199908)42:8<1757::AID-ANR27>3.0.CO;2-Z. Arthritis Rheum. 1999. PMID: 10446878 - The immunogenetic relationship between anti-Ro(SS-A)/La(SS-B) antibody positive Sjögren's/lupus erythematosus overlap syndrome and the neonatal lupus syndrome.
Alexander EL, McNicholl J, Watson RM, Bias W, Reichlin M, Provost TT. Alexander EL, et al. J Invest Dermatol. 1989 Dec;93(6):751-6. doi: 10.1111/1523-1747.ep12284404. J Invest Dermatol. 1989. PMID: 2584740 - Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T, Feist E, Wagenmann A, Kato T, Yamamoto K, Nishioka K, Burmester GR, Hiepe F. Dorner T, et al. J Rheumatol. 1996 Mar;23(3):462-8. J Rheumatol. 1996. PMID: 8832984 - [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
Meyer O. Meyer O. Ann Med Interne (Paris). 2002 Dec;153(8):520-9. Ann Med Interne (Paris). 2002. PMID: 12610426 Review. French. - Antibodies to Ro and La.
Reichlin M. Reichlin M. Ann Med Interne (Paris). 1998 Feb;149(1):34-41. Ann Med Interne (Paris). 1998. PMID: 11490515 Review.
Cited by
- Anti-Ro52 autoantibodies from patients with Sjögren's syndrome inhibit the Ro52 E3 ligase activity by blocking the E3/E2 interface.
Espinosa A, Hennig J, Ambrosi A, Anandapadmanaban M, Abelius MS, Sheng Y, Nyberg F, Arrowsmith CH, Sunnerhagen M, Wahren-Herlenius M. Espinosa A, et al. J Biol Chem. 2011 Oct 21;286(42):36478-91. doi: 10.1074/jbc.M111.241786. Epub 2011 Aug 23. J Biol Chem. 2011. PMID: 21862588 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials